• Toremifene Citrate in Breast Cancer Research

  2026-09-29

  Build more interpretable estrogen receptor assays with Toremifene Citrate, from receptor-binding studies and MCF-7 proliferation screens to carefully controlled translational workflows. This guide combines concentration planning, formulation advice, comparative SERM context, and troubleshooting for breast cancer and endocrinology research.

• Carbenoxolone disodium: Practical Lab Guide

  2026-09-28

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is suitable for exploratory cell and tissue workflows, but should not be treated as a selective mechanistic probe or used to support in vivo efficacy claims without independent validation.

• Deuterium-Labeled Degarelix: Synthesis and Findings

  2026-09-28

  The study reports a 13-step route to deuterium-labeled degarelix acetate, using D₂O/D₃PO₄ to prepare a deuterated amino-acid building block before peptide assembly. The labeled compound was obtained in 14% overall yield, providing a candidate internal standard for pharmacokinetic and clinical research; the paper reports synthesis rather than biological validation.

• Disodium Bicinchoninate in Cardiac Assay Workflows

  2026-09-27

  A practical guide to using this water-soluble reagent in protein-normalization workflows for diabetic cardiac-cell studies. Connect PDE-5/cGMP/PKG biology to assay planning while distinguishing a useful assay component from a direct pathway readout.

• PPL-Fabricated 3D Gold Arrays for Reproducible SERS

  2026-09-26

  The study combines polymer pen lithography with electrostatic gold nanoparticle assembly to create ordered, tunable three-dimensional nanocluster arrays for SERS. The authors report an enhancement factor of 1.67 × 10⁷ and a relative standard deviation below 4.73%, while showing that array architecture can be adjusted through PPL parameters.

• Dextran Sulfate Sodium Salt for Colitis Research

  2026-09-25

  Use Dextran sulfate sodium salt to create a controllable epithelial-injury model for ulcerative colitis research, then connect injury and recovery readouts to emerging epithelial-repair biology. This workflow emphasizes dose piloting, careful intake monitoring, and mechanistic interpretation rather than treating DSS exposure as a stand-in for every feature of human disease.

• Uridine, Trisodium Salt in RNA Workflows

  2026-09-25

  Uridine, Trisodium Salt can support controlled RNA-metabolism and vascular-response experiments, but it is not a substitute for UTP in in vitro transcription. This guide connects careful reagent handling to PRINT-inspired studies while distinguishing established paper findings from practical pilot conditions.

• 5-Aminolevulinic acid HCl in Heme Research

  2026-09-24

  Use 5-Aminolevulinic acid HCl to probe tetrapyrrole-pathway responses, with controls that distinguish precursor availability from pathogen-driven heme regulation. This guide translates a Salmonella–macrophage study into a practical infection-assay workflow while outlining a separate, carefully bounded route to fluorescence and photodynamic research.

• Protease Inhibitor Cocktail: MS-SAFE Workflow

  2026-09-24

  This cocktail helps limit proteolysis during cell or tissue protein extraction and is formulated without AEBSF for mass spectrometry-oriented workflows. Use it in aqueous extraction workflows; add EDTA separately when metalloproteinase inhibition is needed, and do not treat it as a phosphatase inhibitor or a reagent for non-aqueous extraction.

• Sodium Citrate at the SERS Assay Boundary

  2026-09-23

  Sodium citrate can influence biochemical sample conditions, but its role in a SERS workflow should be distinguished from the nanostructure fabrication that creates electromagnetic hot spots. This article uses a polymer-pen-lithography study to show how to set evidence-based controls and avoid assigning citrate effects to substrate architecture.

• PRINT for Safe-Harbor Transgene Insertion

  2026-09-23

  Zhang and colleagues introduce PRINT, an RNA-only strategy that repurposes avian R2 retroelement proteins for site-specific transgene insertion at a multicopy human safe-harbor locus. The study shows that target-primed reverse transcription can insert transgenes without a DNA donor, offering a mechanistically distinct alternative to CRISPR-mediated repair and viral delivery while leaving important questions about fidelity, cell-type range, and in vivo performance.

• Disodium Bicinchoninate: Aqueous Assay Workflows

  2026-09-22

  Disodium bicinchoninate provides a water-based route for chelation-sensitive assay development, protein normalization, and molecular biology workflows where DMSO or ethanol could complicate interpretation. This guide translates its formulation advantages into practical preparation, plate-based testing, troubleshooting, and assay-design choices informed by a recent inflammation study.

• DSS (MW 35000-45000): From Injury to Repair

  2026-09-22

  Dextran sulfate sodium salt is more than a colitis trigger: it is a controllable perturbation for separating epithelial injury from mucosal repair. This guide connects DSS assay timing with the GPR35–KLF5 repair circuitry to improve interpretation in ulcerative colitis research.

• PRINT: RNA-Mediated Safe-Harbor Transgenesis

  2026-09-21

  The PRINT platform uses R2 retroelement proteins and engineered template RNA to synthesize transgenes directly into a multicopy human safe-harbor locus, avoiding donor DNA and extrachromosomal intermediates. The study combines biochemical target-primed reverse transcription assays with primary-cell experiments, showing substantial insertion of multikilobase transgenes while also defining important requirements for junction validation and future optimization.

• Selective Autophagy Tunes IRF3 Stability

  2026-09-21

  The reference study identifies CALCOCO2/NDP52-mediated selective autophagy as a virus-load-dependent mechanism that removes IRF3 and limits excessive type I interferon signaling. It further defines PSMD14-mediated editing of K27-linked ubiquitin chains at IRF3 Lys313 as a counter-regulatory process that preserves basal IRF3 and helps balance antiviral activation with immune suppression.

7926 records 1/529 page Next 12345 下5页 Last page